216 related articles for article (PubMed ID: 18018374)
1. The Part D shuffle. UnitedHealth, Humana lose business.
Vesely R
Mod Healthc; 2007 Oct; 37(40):17. PubMed ID: 18018374
[No Abstract] [Full Text] [Related]
2. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
Thomson Reuters/West
Issue Brief Health Policy Track Serv; 2011 Jan; ():1-28. PubMed ID: 21374839
[No Abstract] [Full Text] [Related]
3. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
Chaps NA
Issue Brief Health Policy Track Serv; 2009 Jan; ():1-26. PubMed ID: 19301435
[No Abstract] [Full Text] [Related]
4. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
Chaps NA
Issue Brief Health Policy Track Serv; 2008 Jan; ():1-23. PubMed ID: 18345558
[No Abstract] [Full Text] [Related]
5. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
Chaps NA
Issue Brief Health Policy Track Serv; 2010 Jan; ():1-19. PubMed ID: 20213917
[No Abstract] [Full Text] [Related]
6. Improving the design of competitive bidding in Medicare Advantage.
Cawley JH; Whitford AB
J Health Polit Policy Law; 2007 Apr; 32(2):317-47. PubMed ID: 17463410
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceuticals and medical devices: Medicare Part D.
; Steiner DJ
Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403844
[No Abstract] [Full Text] [Related]
8. Poor in Part D plans face more premiums in 2010.
Manag Care; 2010 Jan; 19(1):55. PubMed ID: 20131647
[No Abstract] [Full Text] [Related]
9. Part D decisions: like other employers, many states are collecting a new federal subsidy for maintaining retiree drug coverage--but for many, that's not their "final answer".
Burton R; Folkemer D
State Legis; 2006 Sep; 32(8):26-7. PubMed ID: 16958187
[No Abstract] [Full Text] [Related]
10. Examining the impact of Part D on nursing home residents.
Hudson N
Find Brief; 2010 May; 13(4):1-3. PubMed ID: 21121179
[TBL] [Abstract][Full Text] [Related]
11. Toward a rational, value-based drug benefit for Medicare.
Lopert R; Moon M
Health Aff (Millwood); 2007; 26(6):1666-73. PubMed ID: 17978385
[TBL] [Abstract][Full Text] [Related]
12. Medicare part D--what doctors need to know.
Stephenson L
Iowa Med; 2005; 95(6):24-5. PubMed ID: 16425707
[No Abstract] [Full Text] [Related]
13. Pharmaceuticals and medical devices: State Pharmaceutical Assistance Programs (SPAPs). End-of-year issue brief.
Chaps NA
Issue Brief Health Policy Track Serv; 2008 Jan; ():1-15. PubMed ID: 18345559
[No Abstract] [Full Text] [Related]
14. Pharmaceuticals and Medical Devices: Medicare Part D.
Steiner DJ;
Issue Brief Health Policy Track Serv; 2016 Dec; 2016():1-31. PubMed ID: 28252885
[No Abstract] [Full Text] [Related]
15. Part I--Medicare prescription drug coverage (Part D): the promise.
Witten B
Nephrol News Issues; 2006 Jul; 20(8):14, 17-8. PubMed ID: 16859229
[No Abstract] [Full Text] [Related]
16. Lost in the doughnut hole. The drug benefit's woes will worsen as seniors discover shortcomings.
Sloane T
Mod Healthc; 2006 Jan; 36(3):24. PubMed ID: 16445210
[No Abstract] [Full Text] [Related]
17. Part D outdoes expectations. But providers may face more cuts in reimbursement.
DoBias M
Mod Healthc; 2006 Jul; 36(28):8-9. PubMed ID: 16898553
[No Abstract] [Full Text] [Related]
18. Lowering Part D drug costs without direct CMS negotiations.
Sipkoff M
Manag Care; 2009 Sep; 18(9):11-2. PubMed ID: 19886203
[No Abstract] [Full Text] [Related]
19. Medicare program; Medicare Advantage and prescription drug benefit programs: negotiated pricing and remaining revisions. Final rule with comment period.
Fed Regist; 2009 Jan; 74(7):1493-549. PubMed ID: 19143114
[TBL] [Abstract][Full Text] [Related]
20. Medicare Part D.
Bird H
Fam Pract Manag; 2006 Mar; 13(3):23; author reply 23. PubMed ID: 16568589
[No Abstract] [Full Text] [Related]
[Next] [New Search]
